首页> 外文期刊>British journal of ophthalmology >Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients.
【24h】

Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients.

机译:口服维生素C和E作为急性前葡萄膜炎患者的补充治疗:一项针对145名患者的随机双掩盖研究。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the effect of additional oral vitamins C and E on acute anterior uveitis. METHODS: A placebo controlled double masked study on the effect of vitamin C 500 mg in combination with vitamin E 100 mg twice daily in 145 patients with acute anterior uveitis. As a primary end point variable, laser cell/flare measurements were performed. Best corrected and stenopeic visual acuity (VA) testing and clinical variable scores were measured. RESULTS: Laser flare measurements (ph/s) before treatment were 207.1 (SD 258) in the vitamin group and 143.6 (156) in the placebo group. After 3 days corresponding values were 80.2 (129) and 54.7 (82), after 7 days 89.2 (187) (12.5) and 85.8 (208), after 14 days 47.1 (109.5) and 40.5 (116) after 28 days 23.1 (53.6) and 23.1 (48), and after 56 days 15.6 (26) and 15.3 (17). There was no significant difference in time trend between the two treatment groups (RMANOVA; p = 0.53). Baseline VA (logMAR) was 0.106 (0.241) in the vitamin group and 0.128 (0.456) in the placebo group. VA after 3 days was 0. 236 (0.293) and 0.344 ( 0.489), after 7 days 0.204 (0.292) and 0.292 (0.479), after 14 days 0.162 (0.274) and 0.193 (0.454), after 28 days 0.096 (0.232) and 0.158 (0.436), and 0.026 (0.213) and 0.106 (0. 437) after 56 days. Although no significant difference in time trend was detected, evaluation of the VA data of the last time point (56 days) by means of the Mann-Whitney test showed a significantly better VA in the vitamin group (p = 0.01). CONCLUSIONS: There was no significant effect of vitamins C and E on laser flare measurements. The significant effect of the oral vitamins on visual acuity at 8 weeks after start of the oral vitamins C and E may indicate a protective effect in patients with acute anterior uveitis.
机译:目的:探讨额外的口服维生素C和E对急性前葡萄膜炎的影响。方法:安慰剂对照双掩蔽研究对145例急性前葡萄膜炎患者每日两次服用500毫克维生素C和100毫克维生素E的效果。作为主要终点变量,执行了激光孔/火炬测量。测量最佳矫正视力和狭窄视力(VA)测试以及临床变量评分。结果:维他命组治疗前的激光耀斑(ph / s)为207.1(SD 258),安慰剂组为143.6(156)。 3天后对应的值为80.2(129)和54.7(82),7天后对应的值为89.2(187)(12.5)和85.8(208),14天后对应的值为47.1(109.5)和40.5(116),在28天之后为23.1(53.6) )和23.1(48),以及56天后的15.6(26)和15.3(17)。两个治疗组之间的时间趋势无显着差异(RMANOVA; p = 0.53)。维生素组的基线VA(logMAR)为0.106(0.241),安慰剂组为0.128(0.456)。 3天后的VA为0.236(0.293)和0.344(0.489),7天后为0.204(0.292)和0.292(0.479),14天后0.162(0.274)和0.193(0.454),28天后0.096(0.232) 56天后为0.158(0.436),0.026(0.213)和0.106(0.437)。尽管未发现时间趋势有显着差异,但通过Mann-Whitney测试评估最后一个时间点(56天)的VA数据显示,维生素组的VA明显更好(p = 0.01)。结论:维生素C和E对激光耀斑的测量没有显着影响。口服维生素C和E开始后8周,口服维生素对视力的显着影响可能表明对急性前葡萄膜炎患者具有保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号